Subscribe to our mailing list

Enterprise Information Roundup, March 16

Public choices

Arcus rises

in 1st day

Shares of Hayward biopharmaceutical firm Arcus Biosciences jumped 13 % Thursday in its first day of buying and selling on the New York Inventory Trade.

Based in 2015, Arcus develops most cancers immunotherapies, all of that are within the medical improvement stage or earlier. The corporate bought eight million shares for $15 every within the preliminary public providing, elevating $120 million earlier than underwriters’ charges.

Powered by WPeMatico

Author: Techno Info

VN:F [1.9.22_1171]
Rating: 0.0/10 (0 votes cast)
VN:F [1.9.22_1171]
Rating: 0 (from 0 votes)

Author Spotlight